Drug Shortage Report for TOBRAMYCIN INHALATION SOLUTION
Report ID | 38757 |
Drug Identification Number | 02443368 |
Brand name | TOBRAMYCIN INHALATION SOLUTION |
Common or Proper name | TOBRAMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 56 AMPOULES |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-02-05 |
Estimated end date | 2018-06-29 |
Actual end date | 2018-06-18 |
Shortage status | Resolved |
Updated date | 2018-07-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-07-03 | French | Compare |
v9 | 2018-07-03 | English | Compare |
v8 | 2018-05-23 | French | Compare |
v7 | 2018-05-23 | English | Compare |
v6 | 2018-05-23 | French | Compare |
v5 | 2018-05-23 | English | Compare |
v4 | 2018-04-19 | French | Compare |
v3 | 2018-04-19 | English | Compare |
v2 | 2018-02-05 | French | Compare |
v1 | 2018-02-05 | English | Compare |
Showing 1 to 10 of 10